跳至主要内容
临床试验/IRCT20180623040193N1
IRCT20180623040193N1已完成3 期

Evaluation of Donepezil effectiveness on prevention of cognitive impairment caused by electroconvulsivetherapy (ECT) in mood disorder patients

Shahre-kord University of Medical Sciences0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 65 years(—)
性别
All

入选标准

  • Age 15-65 years old
  • Diagnosis of Major depressive disorder by a psychiatrist
  • Diagnosis of bipolar disorder by a psychiatrist
  • Prescribing at least four session of elecctroconvulsivetherapy
  • inform consent

排除标准

  • Dissatisfaction for continued study
  • Mental retardation
  • discontinue treatment before session 4
  • Delirium during treatment
  • Prohibition of acetyl cholinesterase inhibitors because of a cardiac disorder
  • chronic obstructive pulmonary disease
  • Acute peptic ulcer
  • Lack of literacy

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验